Search details
1.
Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective.
Nephrol Dial Transplant
; 38(2): 362-371, 2023 02 13.
Article
in English
| MEDLINE | ID: mdl-35238929
2.
Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort.
Pediatr Nephrol
; 37(3): 601-612, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34476601
3.
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.
Pediatr Nephrol
; 34(11): 2261-2277, 2019 11.
Article
in English
| MEDLINE | ID: mdl-30402748
4.
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.
Pediatr Nephrol
; 34(4): 741-742, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30645679
5.
Glyco-iELISA: a highly sensitive and unambiguous serological method to diagnose STEC-HUS caused by serotype O157.
Pediatr Nephrol
; 34(4): 631-639, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30367236
6.
Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome.
Nephrol Dial Transplant
; 33(4): 635-645, 2018 04 01.
Article
in English
| MEDLINE | ID: mdl-29106598
7.
Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C.
Kidney Int
; 101(6): 1293-1295, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35597592
8.
Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2.
Pediatr Nephrol
; 32(7): 1263-1268, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28343354
9.
Fecal diagnostics in combination with serology: best test to establish STEC-HUS.
Pediatr Nephrol
; 31(11): 2163-70, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27240858
10.
Placental passage of eculizumab and complement blockade in a newborn.
Kidney Int
; 95(4): 996, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30904074
11.
Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation.
Kidney Int Rep
; 8(4): 715-726, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-37069997
12.
Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome.
Clin J Am Soc Nephrol
; 18(6): 759-766, 2023 06 01.
Article
in English
| MEDLINE | ID: mdl-36913245
13.
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study.
Kidney Int Rep
; 8(1): 91-102, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36644349
14.
A young girl with an unusual cause of acute kidney injury: Questions.
Pediatr Nephrol
; 31(11): 2071-3, 2016 11.
Article
in English
| MEDLINE | ID: mdl-26289291
15.
A young girl with an unusual cause of acute kidney injury: Answers.
Pediatr Nephrol
; 31(11): 2075-8, 2016 11.
Article
in English
| MEDLINE | ID: mdl-26289292
16.
Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient.
Front Immunol
; 11: 612706, 2020.
Article
in English
| MEDLINE | ID: mdl-33519821
17.
Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome.
Front Immunol
; 11: 547406, 2020.
Article
in English
| MEDLINE | ID: mdl-33414780
18.
Validity of the Patient Experiences and Satisfaction with Medications (PESaM) Questionnaire.
Patient
; 12(1): 149-162, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30367435
19.
Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).
Patient
; 10(5): 629-642, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28357591
Results
1 -
19
de 19
1
Next >
>>